期刊文献+

P73、CyclinD1在子宫内膜癌中的表达及其相关性研究 被引量:4

Expression and correlation of P73 and CyclinD1 in endometrial carcinoma
暂未订购
导出
摘要 目的:探讨P73、CyclinD1在子宫内膜癌中的表达以及二者的相关性。方法:采用免疫组化SP法对14例正常增殖期子宫内膜、19例不典型增生内膜以及43例子宫内膜癌中P73、CyclinD1的表达进行研究。结果:在子宫内膜癌中,P73和CyclinD1的阳性表达率分别为69.77%和74.42%,明显高于不典型增生内膜(36.84%、52.63%)、正常增殖期子宫内膜(均7.14%)中的表达(P均<0.01)。P73的表达随组织学分级的升高而增强(P<0.05),CyclinD1的表达随手术-病理分期的进展而增强(P<0.01),二者均随肌层浸润深度的增加、淋巴结的转移而表达增强(P均<0.05)。在子宫内膜癌中,P73、CyclinD1表达呈正相关性(r=0.3923,P<0.05)。结论:P73、CyclinD1在子宫内膜癌中均高表达,且具有正向协同作用,在子宫内膜癌的发生、发展中有重要意义。 Objective: To study the expression of P73 and CyclinD1 and the correlation of them in endometrial carcinoma. Methods: In 14 cases of normal proliferative endometrium,19 cases of atypical hyperplasia and 43 cases of endometrial carcinoma, the expressions of P73 and CyclinD1 were detected by means of immunohistochemical SP. Results: In endometrial carcinoma, the positive expression rates of P73 and CyclinD 1 were 69.77% and 74.42%,which were more higher than those in atypical hyperplasia group and normal proliferative endometrium (P〈0.01). The expression of P73 was enhanced with the increasing of histological grade (P〈0.05),while the expression of CyclinD 1 was related to clinical stage (P〈0.01 ).Both of them were associated with myometrial invasion and the lymph node metastasis (P〈0.05).There was a positive correlation between P73 and CyclinD 1 in endometrial carcinoma(r=0.3923, P〈0.05 ). Conclusion: There are overexpressions of P73 and CyelinD1 in endometrial carcinoma and the synergy of them may contribute to the development of endometrial carcinoma.
出处 《天津医科大学学报》 2010年第1期113-116,126,共5页 Journal of Tianjin Medical University
关键词 子宫内膜癌 P73 CYCLIND1 细胞周期调控 免疫组化 Endometrial carcinoma P73 CyclinD1 Regulation of cell cycle Immunohistochemistry
  • 相关文献

参考文献11

  • 1高庆蕾,马丁.子宫内膜癌的分子生物学研究进展[J].中国实用妇科与产科杂志,2002,18(4):250-252. 被引量:8
  • 2Kaghad M, Bonnet H, Yang A, et a l.Monoallelically expressed gene related to p53 at lp36, a region frequently deleted in neuroblastoma and other human cancers [J].Cell, 1997,90(4) : 809.
  • 3Gob TJ, Fey MF, Tobler A. The two faces of p73[J]. Cell Death Diffeer, 2002, 9 (3) : 237.
  • 4Mai M,Yokomizo A,Qian C,et al. Activation of p73 silent allele in lung cancer [J].Cancer Rcs,1998,58 ( 11 ) :2347.
  • 5杨开颜,俞康,李剑敏,陈国荣,黄卡特,朱启建,周韧.P73、P51基因在乳腺癌组织中mRNA的表达及意义[J].中华医学杂志,2006,86(20):1428-1430. 被引量:3
  • 6Ishimoto O, Kawahara C, Enjo K, et al. Possble oncogenic potential of DeltaNp73: a newly identified isoform of human p73 [J]. Cancer Res, 2002, 62 (3) : 636.
  • 7Niwa Y,Hirose K,Matsuo K,et al.Association of p73 G4C14-to- A4T14 polymorphism at exon 2 and p53 Arg72Pro polymorphism with the risk of endometrial cancer in Japanese subjects [J]. Cancer Lett,2005,219(2) : 183.
  • 8Becker K, Pancoska P, Concin N, et al.Pattems of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers [J]. Int J Oncol,2006,29(4):889.
  • 9Wang C, Li Z, Fu M ,et al.Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential [J].Cancer Treat Res, 2004,119 : 217.
  • 10Fu M ,Wang C,Li Z,et al.Minireview: Cyclin DI: normal and abnormal functions [J]. Endocrinology,2004,145(12) :5439.

二级参考文献35

  • 1[1]Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275(5308):1943
  • 2[2]Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers . Nat Genet, 1997, 15(4): 356
  • 3[3]Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res, 1997, 57(11): 2124
  • 4[4]Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 1997, 57 (18): 3935
  • 5[5]Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst, 2000, 92(11): 924
  • 6[6]Marsh DJ, Dahia PL, Caron S, et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet, 1998, 35(11): 881
  • 7[7]Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 1993, 75(5): 1027
  • 8[8]Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med, 1998, 339(8): 511
  • 9[9]Ouyang H, Furukawa T, Abe T, et al. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin Cancer Res, 1998, 4(4):1071
  • 10[10]Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res, 1997, 57(19): 4420

共引文献8

同被引文献52

  • 1吴春凤,何秀萍,田晓宁.p73在子宫内膜癌中的表达[J].哈尔滨医科大学学报,2004,38(3):263-265. 被引量:1
  • 2张思平,杨宾烈,李英勇.KAI1转移抑制蛋白在宫颈鳞癌中的表达[J].河南肿瘤学杂志,2005,18(2):110-112. 被引量:1
  • 3顾华丽,田字彬.ras基因突变与肿瘤的关系[J].青岛大学医学院学报,2005,41(4):372-375. 被引量:14
  • 4Gautschi O, Hugli B, Ziegler A, et al. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung canc- er risk and response to platinum-based chemotherapy in non-small cell lung cancer ( NSCLC ) patients. Lung Cancer,2006, 51 ( 3 ) : 303-311.
  • 5De Vim F, Orditura M, Matano E, et al. A phase II study of bi- weekly oxaliplatin plus infusional 5-fluorouracil and folinic acid ( FOLFOX-4 ) as first-line treatment of advanced gastric cancer pa- tients. Br J Cancer,2005,92(9) : 1644-1649.
  • 6Denny L. The prevention of cervical cancer in developing coun- tries. BJOG,2005, 112(9) :1204-1212.
  • 7Holley SL, Matthias C, Jahnke V, et al. Association of cyclin D1 polymorphism with increased susceptibility to oral sqUamous cell carcinoma. Oral Oncol,2005, 41 (2) : 156-160.
  • 8Bae DS, Cho SB, Kim Y J, et al. Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol, 2001, 81(3) :341-347.
  • 9Vikhanskaya F, Toh WH, Dulloo I, et al. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol,2007, 9(6) :698-705.
  • 10Kommoss S, du Bois A, Ridder R, et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally de- bulked patients : a translational research subprotocol of a random- ised study of the Arbeitsgemeinschaft Gynaekologische Onkolagie Ovarian Cancer Study Group. Br J Cancer, 2007, 96 ( 2 ) : 306- 313.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部